Biolase Inc BIOL

NAS: BIOL | ISIN: US0909112072 11/11/2024

0,004 USD (0,00%)

(0,00%) 11/11/2024

Grafiek Biolase Inc

Grafiek Biolase Inc

1 dag1d 0,00%
1 week1w -27,93%
1 maand1m -63,96%
3 maanden3m -93,04%
6 maanden6m -97,79%
1 jaar1j -99,66%
5 jaar5j -99,18%

Biolase Inc in het nieuws

Toon enkel gratis nieuws

29 januari 2024 · Biolase Reports Unaudited Revenue Growth For Full Year 2023 And Provides Outlook For Full Year 2024 · Persbericht

8 januari 2024 · Biolase Enhances Education Offerings In 2024 Due To Increasing Demand Of Dental Laser Courses Throughout 2023 · Persbericht

3 januari 2024 · Biolase Receives Second Top Workplaces 2023 Award · Persbericht

14 december 2023 · Biolase Receives Top Workplaces 2023 Award · Persbericht

12 december 2023 · BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial · Persbericht

6 december 2023 · BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules · Persbericht

9 november 2023 · Biolase Reports Third Quarter Financial Results; Company Benefitting From Strategic Actions Taken To Streamline Operations And Gain Greater Operational Efficiencies · Persbericht

8 november 2023 · Thinking about buying stock in PaxMedica, Applied Therapeutics, Tharimmune, Singular Genomics Systems, or BIOLASE? · Persbericht

8 november 2023 · Landmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR® Perio Protocol · Persbericht

7 november 2023 · Biolase To Report Third Quarter 2023 Results On November 9, 2023 · Persbericht

Profiel Biolase Inc

Gezondheidstechnologie

Medische Specialiteiten

Productie van tandheelkundige apparatuur

Website: www.biolase.com

Hoofdzetel: Irvine, California Verenigde Staten

CEO: Todd Norbe

Werknemers: 417

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe